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Studies of patients with psychogenic non-epileptic seizures (NES) typically focus upon the phenomenology and outcome of
NES episodes. Little is known, however, about the frequency and nature of other somatic symptoms such as pain, in this
population. To assess the frequency, location and severity of symptoms of pain among NES patients, we administered structured
interviews to 56 patients, 6 or more months following the diagnosis of psychogenic non-epileptic seizures (NES). Patients were
recruited from a tertiary hospital-based epilepsy monitoring unit. Seventy-seven percent of patients suffered from moderate to
severe pain, most commonly headache (61%), while neck pain and backache were also common. Twenty-six of 27 patients
with persistent NES vs. 17 of 29 patients whose NES resolved experienced moderate to severe pain (P < 0.001). Pain is an
under-recognized problem that occurs frequently and with significant severity among NES patients. Pain symptoms are more
common among patients with persistent NES than those whose NES resolve.
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Psychogenic non-epileptic seizures (NES) are clinical
events that resemble epileptic attacks but are not as-
sociated with physiologic central nervous system dys-
function1, 2. While numerous NES studies3, 4 have fo-
cused upon the phenomenology of non-epileptic at-
tacks, few investigations have examined the frequency
and nature of other conversion symptoms in this pop-
ulation. Such symptoms need to be recognized since
they may impair occupational and social function and
quality of life. NES patients classified as having a
good prognosis based on resolution or improved NES
frequency may in fact have a poor outcome if other
significant symptoms persist. Our goal, therefore, was
to assess the frequency, location and severity of one
type of somatic symptom (pain) in this population, and
to determine how commonly moderate to severe pain
occurs even in patients whose NES has resolved or im-
proved.1059–1311/99/070424 + 03 $12.00/0MATERIALS AND METHODS
Details of methodology were described previously5 in
another report that examined other variables among
our NES patients. A brief summary of the methods fol-
lows.
Population
We identified patients over the age of 12 years, di-
agnosed with NES between the dates of 1990 and
1996 at the New York University Hospital for Joint
Diseases Comprehensive Epilepsy Center. The NES
diagnosis was based on a comprehensive neurological
and psychiatric evaluation as well as video-EEG mon-
itoring that captured characteristic episodes during the
recording. Episodes identified as NES were not asso-
ciated with electroencephalographic seizure correlate
nor post-ictal prolactin elevation, and were clinically
atypical for epileptic seizures3, 6. All patients in thisc© 1999 BEA Trading Ltd
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Table 1: Pain symptoms.
Type of paina Resolved Persistent All cases
(n = 29) (n = 27) (n = 56)
(n, % (n, %) (n,%)
within each
outcome
category)
Backache 8 (27.6%) 7 (25.9%) 15 (26.8%)
Headache 12 (41.4%) 22 (81.5%) 34 (60.7%)
Neck pain 7 (24.1%) 6 (22.2%) 13 (23.2%)
Other pain 6 (20.7%) 5 (18.5%) 11 (19.6%)
Patients 17 (58.6%) 26 (96.3%) 43 (76.8%)
reporting P < 0.001
moderate to
severe pain of
any type
aCategories are not mutually exclusive.study were diagnosed as having a conversion disor-
der; none had factitious disorder or malingering. The
diagnosis of NES was presented during the hospital
stay (>90%) or at the first outpatient follow-up visit
(<10%) by the attending neurologist as previously
described7, 8. The discussion stressed patient dignity,
emphasizing that the disorder is ‘serious and real’ but
different than epilepsy.
We uniformly recommended further evaluation and
treatment by a psychotherapist or psychiatrist. Most
patients were returned to the original health care
provider with arrangements for local psychotherapy
and psychopharmacologic intervention as indicated.
We excluded patients who had:
(1) Episodes suggestive of possible current or past
epileptic seizures (e.g. patients with episodes as-
sociated with major body injuries).
(2) Episodes captured on video-EEG that were not
typical of the usual episodes described by the
patient.
(3) Episodes with clinical features suggestive of
possible simple partial epileptic seizures or ex-
tratemporal complex partial seizures such as
stereotypic features or duration, or occurrence
during sleep9, 10.
Testing
Six or more months after patients received the NES
diagnosis, we contacted patients who met study cri-
teria. All study patients signed an institutional review
board-approved consent form and agreed to undergo a
telephone-based structured interview.
NES outcome was defined as ‘resolved’ (episode-
free), or persistent (all others).
In the current study, we asked patients whether
they suffer from pain symptoms that were significant
enough to seek medical attention, persistent (lasting
more than several months) and occurring near the time
of NES diagnosis and/or follow-up. We inquired about
the location of the pain and asked patients to rate the
pain as mild, moderate or severe.
Statistics
We used the Fisher exact two-tailed test to assess the
relationship of NES outcome with pain symptoms.
RESULTS
Seventy-six patients met study criteria. Eight patients
could not be reached, two died (neither due to suicide)and 10 declined to participate, leaving 56 patients:
16 (28.6%) male; 40 (71.4%) female who entered the
study. Mean duration of follow-up was 17.9 months
(SD = ±10.6 months). Mean age at the time of NES
diagnosis was 33 years (range 12–58 years; SD =
±12 years); mean age at follow-up was 34.73 years
(range 14–61 years; SD = ±11.9 years). Mean age of
NES onset was 27.8 years (range 9–58 years; SD =
±12.6). Mean NES duration was 8 years (range 1–
38 years; SD = ±8.9).
NES outcome and patients’ descriptions about pain
symptoms are displayed in Table 1. The majority of
patients had some type of pain symptom; 77% re-
ported moderate to severe levels of pain. Headache
was the single most common type of pain; backache
and neck pain were the second and third most com-
mon pain symptom, respectively. Fifty-nine percent
of patients whose NES resolved and 96% of patients
with persistent NES experienced moderate to severe
pain of one or more locations. Twenty-six of 27 pa-
tients with persistent NES vs. 17 of 29 patients whose
NES resolved experienced moderate to severe pain
(P < 0.001).Among 29 patients with abolished NES, 13 (44.8%)
had a single location for pain vs. 16 (55.2%) had mul-
tiple pain symptoms. Among 27 patients with persis-
tent NES, 14 (51.9%) had a single location for pain vs.
13 (28.1%) with multiple pain symptoms (P = NS).
DISCUSSION
We found chronic pain symptoms of moderate to se-
vere intensity occurred in more than three-quarters
of NES patients. Headache, backache, neck pain and
other pain syndromes were present in decreasing or-
der of frequency. These patients all sought medical
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tor. Neurology 1996; 46: 1786–1787.treatment for these symptoms and in many cases un-
derwent extensive diagnostic studies, therapeutic tri-
als, and in some cases, surgery. The high frequency of
these symptoms in patients with NES and the higher
frequency in patients with persistent NES, suggest that
some symptoms may result from psychological mech-
anisms.
The pathogenesis of pain symptoms in NES patients
remains poorly defined. In some cases, physiologic
disorders (e.g. migraine, central pain) or structural le-
sions (e.g. lumbar disc herniation, endometriosis) can
cause chronic disabling pain. However, the high fre-
quency of refractory pain syndromes especially among
patients with persistent NES, suggests that in some
cases psychological factors were a contributing or pre-
dominant cause. Future studies should assess rates
of pain symptoms in patients with NES compared to
other disorders.
DSM-IV categorizes conversion disorder within the
family of Somatoform Disorders. Somatoform dis-
orders are characterized by physical symptoms that
mimic medical or neurologic disease but are not fully
explainable by a medical or neurologic condition and
are not due to substance abuse or another mental disor-
der. In addition to conversion disorder, other somato-
form disorders include Somatization Disorder, Undif-
ferentiated Somatoform Disorder, Pain Disorder, and
Hypochondriasis. The predominant feature of somato-
form disorders is pain or discomfort. Among the cri-
teria for Somatization Disorder, four pain symptoms
must be present. Given the central role of pain in so-
matoform disorders, one would suspect a high fre-
quency of psychogenic pain symptoms in patients with
any somatoform disorder, including conversion NES.
Bowman and Markand11 also found severe, unex-
plained headaches were common in their NES se-
ries. We previously reported four patients with re-
fractory basilar artery migraine who underwent video-
EEG recording to exclude epilepsy and whose neuro-
logic symptoms and headaches were conversion symp-
toms12. Currently, somatoform disorders are infre-
quently diagnosed in patients with chronic headache.
In large measure, this may result from the lack of a
clear diagnostic test. Similarly, prior to the widespread
use of video-EEG monitoring, NES were diagnosed
much less frequently13. We speculate that many cases
of chronic headache, back pain and other neurogenic
pain syndromes due primarily to a somatoform disor-
der go unrecognized. Further, many patients with NES
may have coexistent somatoform symptoms that are
inappropriately treated. For example, one of the NESpatients in this series had more than six abdominal
surgeries for pain but a review of operative notes and
pathology reports failed to identify a clear pathogenic
process (other than adhesions found in the latter two
surgeries, likely a result of earlier surgery).
Our study suggests that future investigations should
be performed to determine what effect revealing
NES diagnosis has on the frequency and severity of
headache and other pain symptoms. In some patients,
resolution of the NES may be followed by the devel-
opment of substitute symptoms of pain. Prospective
studies are needed to better screen for patients at risk,
and identify the frequency of symptom substitution.
Our study should also inspire future examinations of
other types of symptoms, since in some patients, NES
may not be the most serious manifestation of their so-
matoform disorder.
